Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
104593901000001114 | Atezolizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
104594001000001112 | Atezolizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Atezolizumab | Is a | Product containing monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
Atezolizumab | Is a | Medicinal product acting as antineoplastic agent (product) | false | Inferred relationship | Existential restriction modifier | ||
Atezolizumab | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
Atezolizumab | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atezolizumab 840mg/14ml solution for infusion vials | Is a | False | Atezolizumab | Inferred relationship | Existential restriction modifier | |
Atezolizumab 1.2g/250ml infusion bags | Is a | False | Atezolizumab | Inferred relationship | Existential restriction modifier | |
Atezolizumab 1.2g/20ml solution for infusion vials | Is a | False | Atezolizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets